🟢 Intravenous Infusions is trading 8.16% up

Intravenous Infusions is trading 8.16% up at GHS 0.53, with no clearly linked catalyst identified for the October 7, 2026 move.

• The latest located market report tied the same price and gain to October 5, rather than documenting a fresh October 7 catalyst.
• The company’s website lists an AGM scheduled for October 23, but the notice does not establish a cause for the share move.
• Available evidence does not support attributing the move to broader market sentiment or a specific event.